Alegre-Díaz Jesus, Herrington William, López-Cervantes Malaquías, Gnatiuc Louisa, Ramirez Raul, Hill Michael, Baigent Colin, McCarthy Mark I, Lewington Sarah, Collins Rory, Whitlock Gary, Tapia-Conyer Roberto, Peto Richard, Kuri-Morales Pablo, Emberson Jonathan R
School of Medicine, National Autonomous University of Mexico (UNAM), Mexico City.
Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford, Oxford, United Kingdom.
N Engl J Med. 2016 Nov 17;375(20):1961-1971. doi: 10.1056/NEJMoa1605368.
Most large, prospective studies of the effects of diabetes on mortality have focused on high-income countries where patients have access to reasonably good medical care and can receive treatments to establish and maintain good glycemic control. In those countries, diabetes less than doubles the rate of death from any cause. Few large, prospective studies have been conducted in middle-income countries where obesity and diabetes have become common and glycemic control may be poor.
From 1998 through 2004, we recruited approximately 50,000 men and 100,000 women 35 years of age or older into a prospective study in Mexico City, Mexico. We recorded the presence or absence of previously diagnosed diabetes, obtained and stored blood samples, and tracked 12-year disease-specific deaths through January 1, 2014. We accepted diabetes as the underlying cause of death only for deaths that were due to acute diabetic crises. We estimated rate ratios for death among participants who had diabetes at recruitment versus those who did not have diabetes at recruitment; data from participants who had chronic diseases other than diabetes were excluded from the main analysis.
At the time of recruitment, obesity was common and the prevalence of diabetes rose steeply with age (3% at 35 to 39 years of age and >20% by 60 years of age). Participants who had diabetes had poor glycemic control (mean [±SD] glycated hemoglobin level, 9.0±2.4%), and the rates of use of other vasoprotective medications were low (e.g., 30% of participants with diabetes were receiving antihypertensive medication at recruitment and 1% were receiving lipid-lowering medication). Previously diagnosed diabetes was associated with rate ratios for death from any cause of 5.4 (95% confidence interval [CI], 5.0 to 6.0) at 35 to 59 years of age, 3.1 (95% CI, 2.9 to 3.3) at 60 to 74 years of age, and 1.9 (95% CI, 1.8 to 2.1) at 75 to 84 years of age. Between 35 and 74 years of age, the excess mortality associated with previously diagnosed diabetes accounted for one third of all deaths; the largest absolute excess risks of death were from renal disease (rate ratio, 20.1; 95% CI, 17.2 to 23.4), cardiac disease (rate ratio, 3.7; 95% CI, 3.2 to 4.2), infection (rate ratio, 4.7; 95% CI, 4.0 to 5.5), acute diabetic crises (8% of all deaths among participants who had previously diagnosed diabetes), and other vascular disease (mainly stroke). Little association was observed between diabetes and mortality from cirrhosis, cancer, or chronic obstructive pulmonary disease.
In this study in Mexico, a middle-income country with high levels of obesity, diabetes was common, glycemic control was poor, and diabetes was associated with a far worse prognosis than that seen in high-income countries; it accounted for at least one third of all deaths between 35 and 74 years of age. (Funded by the Wellcome Trust and others.).
大多数关于糖尿病对死亡率影响的大型前瞻性研究都集中在高收入国家,这些国家的患者能够获得较为良好的医疗护理,并能接受治疗以建立和维持良好的血糖控制。在这些国家,糖尿病导致的任何原因死亡率增加不到一倍。在肥胖和糖尿病已变得常见且血糖控制可能较差的中等收入国家,很少有大型前瞻性研究。
从1998年到2004年,我们在墨西哥城招募了约50000名35岁及以上男性和100000名35岁及以上女性参与一项前瞻性研究。我们记录是否存在先前诊断的糖尿病,采集并储存血样,并追踪至2014年1月1日的12年特定疾病死亡情况。仅将因急性糖尿病危象导致的死亡接受为糖尿病作为潜在死因。我们估计了招募时患有糖尿病的参与者与未患糖尿病的参与者之间的死亡率比;主要分析排除了患有糖尿病以外其他慢性病的参与者的数据。
招募时,肥胖很常见,糖尿病患病率随年龄急剧上升(35至39岁为3%,60岁时超过20%)。患有糖尿病的参与者血糖控制较差(糖化血红蛋白水平均值[±标准差]为9.0±2.4%),其他血管保护药物的使用率较低(例如,30%患有糖尿病的参与者在招募时接受抗高血压药物治疗,1%接受降脂药物治疗)。先前诊断的糖尿病与35至59岁时任何原因死亡率比为5.4(95%置信区间[CI],5.0至6.0)、60至74岁时为3.1(95%CI,2.9至3.3)以及75至84岁时为1.9(95%CI,1.8至2.1)相关。在35至74岁之间,与先前诊断的糖尿病相关的额外死亡率占所有死亡的三分之一;最大的绝对额外死亡风险来自肾脏疾病(死亡率比,20.1;95%CI,17.2至23.4)、心脏病(死亡率比,3.7;95%CI,3.2至4.2)、感染(死亡率比,4.7;95%CI,4.0至5.5)、急性糖尿病危象(先前诊断患有糖尿病的参与者中所有死亡的8%)以及其他血管疾病(主要是中风)。糖尿病与肝硬化、癌症或慢性阻塞性肺疾病导致的死亡率之间几乎没有关联。
在墨西哥这个肥胖程度高的中等收入国家进行的这项研究中,糖尿病很常见,血糖控制较差,且糖尿病与高收入国家相比预后要差得多;它占35至74岁所有死亡的至少三分之一。(由惠康信托基金会及其他机构资助。)